GlassScriptPhysician profile
Amanda M Schultz
NPI 1578552725
$680.17
in general payments reported to CMS, 2019-2025
9 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.94 · 2022: $141 · 2023: $15.52 · 2024: $66.89 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $188.46 | 2021-2022 | |
| Lilly USA, LLC | $125.00 | 2025 | Zepbound |
| Corcept Therapeutics | $124.98 | 2025 | Korlym |
| Novo Nordisk INC | $111.31 | 2025 | Wegovy |
| Astellas Pharma US INC | $41.94 | 2021 | |
| Neurocrine Biosciences, INC. | $33.15 | 2023-2024 | Ingrezza |
| Impulse Dynamics (USA) INC. | $27.33 | 2024 | Optimizer |
| Janssen Biotech, INC. | $21.93 | 2024 | Tremfya, Simponi, Stelara |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.